Literature DB >> 2126740

Mechanisms of nitrate tolerance: a review.

R J Katz1.   

Abstract

With the increased use of long-acting nitroglycerin preparations, there has been greater recognition of the problem of nitrate tolerance. In recent years extensive research has broadened our understanding of the mechanisms of nitroglycerin action and the mechanisms of drug attenuation. This paper reviews the current state of knowledge regarding nitroglycerin tolerance, with an emphasis on the concepts of cellular and neurohumoral mechanisms of drug attenuation. The discussion includes potential approaches to prevent nitrate tolerance, including the introduction of a nitrate-free interval, or concomitant administration of sulfhydryl donors or neurohumoral blocking agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126740     DOI: 10.1007/bf01857640

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  48 in total

1.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

Authors:  M D Winniford; P L Kennedy; P J Wells; L D Hillis
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

2.  Metabolism of ethylene glycol dinitrate (ethylene dinitrate) in the rat following repeated administration.

Authors:  D G Clark; M H Litchfield
Journal:  Br J Ind Med       Date:  1969-04

3.  Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

Authors:  U Elkayam; D Kulick; N McIntosh; A Roth; W Hsueh; S H Rahimtoola
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

4.  Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.

Authors:  N Sharpe; R Coxon; M Webster; R Luke
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

5.  A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction.

Authors:  Y Lis; D Bennett; G Lambert; D Robson
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

6.  Tolerance to organic nitrates: clinical and experimental perspectives.

Authors:  P W Armstrong; J A Moffat
Journal:  Am J Med       Date:  1983-06-27       Impact factor: 4.965

7.  Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

Authors:  J Torresi; J D Horowitz; G J Dusting
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

8.  Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol.

Authors:  K L Axelsson; R G Andersson; J E Wikberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-05

9.  Mechanisms for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine.

Authors:  H L Fung; S Chong; E Kowaluk; K Hough; M Kakemi
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

10.  Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation.

Authors:  C A Gruetter; S M Lemke
Journal:  Eur J Pharmacol       Date:  1985-04-23       Impact factor: 4.432

View more
  5 in total

Review 1.  An update on nitrate tolerance: can it be avoided?

Authors:  S R Maxwell; M J Kendall
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

Review 2.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog.

Authors:  H Yamada; F Yoneyama; K Satoh; N Taira
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

4.  Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.

Authors:  K Phillips; S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 5.  Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.

Authors:  M Burnier; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.